CLINICAL_TRIALS
trial_result
· 2023-10-26
Clinical Trial Update: Comparing the Efficacy of Hybrid, High-dose Dual and Bismuth Quadruple Therapies [Phase 3]
Summary
Phase 3 trial comparing hybrid, high-dose dual, and bismuth quadruple therapies for Helicobacter pylori infection has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Kaohsiung Veterans General Hospital. | Conditions: Helicobacter Pylori Infection | Phase 3 | Status: COMPLETED